RESUMO
Marine microorganisms often produce exopolysaccharides with novel structures and diverse biological activities due to their specific marine environment. The novel active exopolysaccharides from marine microorganisms have become an important research area in new drug discovery, and show enormous development prospects. In the present study, a homogeneous exopolysaccharide from the fermented broth of the mangrove endophytic fungus Penicillium janthinellum N29, designated as PJ1-1, was obtained. The results of chemical and spectroscopic analyses showed that PJ1-1 was a novel galactomannan with a molecular weight of about 10.24 kDa. The backbone of PJ1-1 was composed of â2)-α-d-Manp-(1â, â4)-α-d-Manp-(1â, â3)-ß-d-Galf-(1â and â2)-ß-d-Galf-(1â units with partial glycosylation at C-3 of â2)-ß-d-Galf-(1â unit. PJ1-1 had a strong hypoglycemic activity in vitro, evaluated using the assay of α-glucosidase inhibition. The anti-diabetic effect of PJ1-1 in vivo was further investigated using mice with type 2 diabetes mellitus induced by a high-fat diet and streptozotocin. The results indicated that PJ1-1 markedly reduced blood glucose level and improved glucose tolerance. Notably, PJ1-1 increased insulin sensitivity and ameliorated insulin resistance. Moreover, PJ1-1 significantly decreased the levels of serum total cholesterol, triglyceride and low-density lipoprotein cholesterol, enhanced the level of serum high-density lipoprotein cholesterol and alleviated dyslipidemia. These results revealed that PJ1-1 could be a potential source of anti-diabetic agent.
Assuntos
Diabetes Mellitus Tipo 2 , Penicillium , Camundongos , Animais , Fungos , Penicillium/química , Hipoglicemiantes/farmacologia , Colesterol , GlicemiaRESUMO
Algae accumulate large amounts of polysaccharides in their cell walls or intercellular regions. Polysaccharides from algae possess high potential as promising candidates for marine drug development. In this study, a sulfated polysaccharide, UCP, from the green alga Ulva conglobata Kjellman was obtained by water extraction, anion-exchange, and size-exclusion chromatography purification, and its structure was characterized by a combination of chemical and spectroscopic methods. UCP mainly consisted of â4)-α/ß-l-Rhap-(1â, â4)-ß-d-Xylp-(1â and â4)-ß-d-GlcAp-(1â residues. Sulfate ester groups were substituted mainly at C-3 of â4)-l-Rhap-(1â and C-2 of â4)-ß-d-Xylp-(1â. Partial glycosylation was at C-2 of â4)-α-l-Rhap-(1â residues. UCP possessed a potent immunomodulatory effect in vitro, evaluated by the assays of lymphocyte proliferation and macrophage phagocytosis. The immunomodulatory activity of UCP in vivo was further investigated using immunosuppressive mice induced by cyclophosphamide. The results showed that UCP markedly increased the spleen and thymus indexes and ameliorated the cyclophosphamide-induced damage to the spleen and thymus. UCP could increase the levels of white blood cells, lymphocytes, and platelets, and improve the hematopoietic inhibition caused by cyclophosphamide. Moreover, UCP significantly promoted the secretions of the immunoglobulin (Ig)G, IgE, and IgM. The data demonstrated that UCP is a novel sulfated polysaccharide and may be a promising immunomodulatory agent.
Assuntos
Sulfatos , Ulva , Animais , Ciclofosfamida/farmacologia , Carboidratos da Dieta , Camundongos , Polissacarídeos/química , Polissacarídeos/farmacologia , Sulfatos/química , Sulfatos/farmacologia , Ulva/químicaRESUMO
Marine macroalgae are efficient producers of sulfated polysaccharides. The algal sulfated polysaccharides possess diverse bioactivities and peculiar chemical structures, and represent a great potential source to be explored. In the present study, a heparinoid-active sulfated polysaccharide was isolated from the green alga Cladophora oligoclada. Results of chemical and spectroscopic analyses indicated that the sulfated polysaccharide was composed of â6)-ß-d-Galp-(1â, ß-d-Galp-(1â, â6)-α-d-Glcp-(1â and â3)-ß-d-Galp-(1â units with sulfate esters at C-2/C-4 of â6)-ß-d-Galp-(1â, C-6 of â3)-ß-d-Galp-(1â and C-3 of â6)-α-d-Glcp-(1â units. The branches consisting of ß-d-Galp-(1â and â6)-ß-d-Galp-(1â units were located in C-3 of â6)-ß-d-Galp-(1â units. The sulfated polysaccharide exhibited potent anticoagulant activity in vitro and in vivo as evaluated by activated partial thromboplastin time (APTT), thrombin time, and the fibrinogen level. For the APTT, the signal for clotting time was more than 200 s at 100 µg/mL in vitro and at 15 mg/kg in vivo. The obvious thrombolytic activity of the sulfated polysaccharide in vitro was also found. The mechanism analysis of anticoagulant action demonstrated that the sulfated polysaccharide significantly inhibited the activities of all intrinsic coagulation factors, which were less than 1.0% at 50 µg/mL, but selectively inhibited common coagulation factors. Furthermore, the sulfated polysaccharide strongly stimulated the inhibition of thrombin by potentiating antithrombin-III (AT-III) or heparin cofactor-II, and it also largely promoted the inhibition of factor Xa mediated by AT-III. These results revealed that the sulfated polysaccharide from C. oligoclada had potential to become an anticoagulant agent for prevention and therapy of thrombotic diseases.
Assuntos
Anticoagulantes/farmacologia , Clorófitas , Polissacarídeos/farmacologia , Animais , Anticoagulantes/química , Organismos Aquáticos , Coagulação Sanguínea/efeitos dos fármacos , Masculino , Modelos Animais , Tempo de Tromboplastina Parcial , Polissacarídeos/química , Ratos , Ratos Sprague-Dawley , Relação Estrutura-Atividade , Sulfatos , Tempo de TrombinaRESUMO
This study designed to evaluate efficacy and safety profile of Mesenchymal stem cells (MSCs) versus Acetyl cysteine (NACys) in the Chinese patients with Chronic renal failure (CRF). The CRF patients having eGFR less than 60ml per minute per 1.73m2 randomly assigned to MSCs (N=100) or NACys (N=100) (1:1) for 8 weeks. MSCs administered as intravenous infusion of marrow-derived autologous MSCs (1 × 106 to 2 × 106/kg) reperfusion, whereas, another group received NACys 600mg orally twice a day for 8 weeks. The efficacy variables include: creatinine; cystatin C; TGF-ß levels; oxidants/reactive oxygen species production induced by TGF-ß; collagen levels (type 1 and 4); urinary albumin/creatinine ratio and Glomerular area. Safety was also assesed. Both the treatments significantly decreased creatinine, cystatin C and reactive oxygen species from baseline, however, reduction in creatinine, cystatin C, and reactive oxygen species level from baseline was significantly higher in patient treated with MSCs (N=100) as compared to NACys (N=100). Moreover, improvement in renal and systemic functional parameters from baseline was significantly higher in patient treated with MSCs as compared to NACys. Overall, MSCs offer significantly greater improvement in renal function as compared to NACys in Chinese CRF patients.
Assuntos
Acetilcisteína/uso terapêutico , Sequestradores de Radicais Livres/uso terapêutico , Falência Renal Crônica/terapia , Transplante de Células-Tronco Mesenquimais/métodos , Idoso , China , Creatinina/metabolismo , Feminino , Taxa de Filtração Glomerular , Humanos , Falência Renal Crônica/metabolismo , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Transplante Autólogo/métodos , Resultado do TratamentoRESUMO
The polysaccharide from green alga Cladophora oligoclada, OHSS2, was a sulfated galactoarabinan which was constituted by a backbone of (1 â 4)-ß-l-arabinopyranose units with partial sulfate at C-3 of (1 â 4)-ß-l-arabinopyranose units. The side chains containing (1 â 4)-ß-l-arabinopyranose, (1 â 4)-ß-d-galactopyranose and/or (1 â 4,6)-ß-d-galactopyranose units were in C-2/C-3 of (1 â 4)-ß-l-arabinopyranose units. OHSS2 had strong anti-diabetic activity in vitro assessed by inhibition of human islet amyloid polypeptide (hIAPP) aggregation. The mechanism analysis of anti-diabetic activity showed that OHSS2 diminished the production of intracellular reactive oxygen species and alleviated hIAPP aggregation-induced oxidative stress in NIT-1 cells. OHSS2 stabilized mitochondrial membrane potential, and enhanced the mitochondrial complex I, II or III activity and ATP level. Thus, OHSS2 effectively protected mitochondria from hIAPP aggregation-induced damage. Furthermore, OHSS2 was co-localized with mitochondria and could have a direct influence on mitochondrial function. These results revealed that OHSS2 had potential as a novel anti-diabetic agent.
Assuntos
Clorófitas/química , Galactanos/farmacologia , Hipoglicemiantes/farmacologia , Polipeptídeo Amiloide das Ilhotas Pancreáticas/antagonistas & inibidores , Sulfatos/farmacologia , Animais , Células Cultivadas , Galactanos/química , Galactanos/isolamento & purificação , Hipoglicemiantes/química , Hipoglicemiantes/isolamento & purificação , Polipeptídeo Amiloide das Ilhotas Pancreáticas/metabolismo , Camundongos , Estresse Oxidativo/efeitos dos fármacos , Agregados Proteicos/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo , Sulfatos/química , Sulfatos/isolamento & purificaçãoRESUMO
A sulfated polysaccharide from the green alga Chaetomorpha linum, designated CLS4, was isolated by water extraction, anion-exchange and size-exclusion chromatography. Chemical and spectroscopic analyses demonstrated that CLS4 was a sulfated arabinogalactan, which was constituted by (1â6)-ß-d-galactopyranose and (1â5)-α-l-arabinofuranose residues with sulfate groups at C-2/ C-3 of (1â5)-α-l-arabinofuranose and C-2/C-4 of (1â6)-ß-d-galactopyranose. CLS4 possessed strong anticoagulant activity in vitro or in vivo as evaluated by activated partial thromboplastin time and thrombin time assays. CLS4 largely inhibited the activities of the coagulation factors XII, XI, IX and VIII. CLS4 was a potent thrombin inhibitor mediated by antithrombin III (ATIII) or heparin cofactor II, and it also effectively stimulated the factor Xa inhibition by potentiating ATIII. Moreover, CLS4 had a high thrombolytic activity in vitro as assessed by clot lytic rate assay. The results suggested that CLS4 could be a promising source of anticoagulant agent.